Analystreport

Capricor Therapeutics (NASDAQ:CAPR) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors